| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $16.29B | +4.9% |
| Gross profit | $12.09B | — |
| Operating income | $-3.20B | — |
| Net income | $-4.24B | -183.5% |
| Gross margin | 74.2% | Net margin -26.0% |
| Segment | Revenue | Share |
|---|---|---|
| US | $8.51B | 52.3% |
| Non Us | $5.84B | 35.8% |
| Animal Healthsegment | $1.79B | 11.0% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $4.20B | 25.8% |
| R&D | $12.59B | 77.3% |
| SG&A | $2.70B | 16.6% |
| Tax & other | $1.04B | 6.4% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
META ・ MET ・ MTD ・ MGM ・ MCHP ・ MU ・ MSFT ・ MAA ・ MRNA ・ TAP ・ MDLZ ・ MPWR
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies